[1]
|
Haimes, J.D., Stewart, C.J.R., Kudlow, B.A., et al. (2017) Uterine Inflammatory Myofibroblastic Tumors Frequently Harbor ALK Fusions with IGFBP5 and THBS1. The American Journal of Surgical Pathology, 41, 773-780.
https://doi.org/10.1097/PAS.0000000000000801
|
[2]
|
Rabban, J.T., Zaloudek, C., Shekitka, K.M., et al. (2005) In-flammatory Myofibroblastic Tumor of the Uterus: A Clinicopathologic Study of 6 Cases Emphasizing Distinction from Aggressive Mesenchymal Tumors. The American Journal of Surgical Pathology, 29, 1348-1355. https://doi.org/10.1097/01.pas.0000172189.02424.91
|
[3]
|
Bahadori, M. and Liebow, A.A. (1973) Plasma Cell Granulomas of the Lung. Cancer, 31, 191-208.
https://doi.org/10.1002/1097-0142(197301)31:1<191::AID-CNCR2820310127>3.0.CO;2-D
|
[4]
|
Gilks, C., Tay-lor, G. and Clement, P. (1987) Inflammatory Pseudotumor of the Uterus. International Journal of Gynecological Pa-thology, 6, 275-286. https://doi.org/10.1097/00004347-198709000-00008
|
[5]
|
Olgan, S., Saatli, B. and Okyay, R.E. (2011) Hysteroscopic Excision of Inflammatory Myofibroblastic Tumor of the Uterus: As Case Report and Brief Review. European Journal of Obstetrics & Gynecology and Reproductive Biology, 157, 234-236. https://doi.org/10.1016/j.ejogrb.2011.02.016
|
[6]
|
Butrynski, J.E., D’Adamo, D.R., Hornick, J.L., et al. (2010) Crizotinib in ALK-Rearranged Inflammatory Myofibroblastic Tumor. The New England Journal of Medicine, 363, 1727-1733. https://doi.org/10.1056/NEJMoa1007056
|
[7]
|
Shintaku, M. and Fukushima, A. (2006) Inflammatory Myofibroblastic Tumor of the Uterus with Prominent Myxoid Change. Pathology International, 56, 625-628. https://doi.org/10.1111/j.1440-1827.2006.02018.x
|
[8]
|
Parra-Herran, C., Quick, C.M., Howitt, B.E., et al. (2015) Inflammatory Myofibroblastic Tumor of the Uterus: Clinical and Pathologic Review of 10 Cases Including a Subset with Aggressive Clinical Course. The American Journal of Surgical Pathology, 39, 157-168. https://doi.org/10.1097/PAS.0000000000000330
|
[9]
|
Mandato, V.D., Valli, R., Mastrofilippo, V., Bisagni, A., Aguzzoli, L. and La Sala, G.B. (2017) Uterine Inflammatory Myofibroblastic Tumor: More Common than Expected: Case Report and Review. Medicine (Baltimore), 96, e8974.
https://doi.org/10.1097/MD.0000000000008974
|
[10]
|
Pickett, J.L., Chou, A. andrici, J.A., et al. (2017) Inflamma-tory Myofibroblastic Tumors of the Female Genital Tract Are Under-Recognized: A Low Threshold for ALK Immuno-histochemistry Is Required. The American Journal of Surgical Pathology, 41, 1433-1442. https://doi.org/10.1097/PAS.0000000000000909
|
[11]
|
Shukla, P.S. and Mittal, K. (2019) Inflammatory Myofibro-blastic Tumor in Female Genital Tract. Archives of Pathology & Laboratory Medicine, 143, 122-129. https://doi.org/10.5858/arpa.2017-0575-RA
|
[12]
|
Bennett, J.A., Nardi, V., Rouzbahman, M., Morales-Oyarvide, V., Nielsen, G.P. and Oliva, E. (2017) Inflammatory Myofibroblastic Tumor of the Uterus: A Clinicopathological, Immuno-histochemial and Molecular Analysis of 13 Cases Highlighting Their Broad Morphologic Spectrum. Modern Pathology, 30, 1489-1503.
https://doi.org/10.1038/modpathol.2017.69
|
[13]
|
Zhang, J., Li, Y. and Lou, L. (2018) Uterine Metastases Originat-ing from a Pulmonary Inflammatory Myofibroblastic Tumor. Journal of Cancer Research and Therapeutics, 14, S257-S259. https://doi.org/10.4103/0973-1482.172129
|
[14]
|
Coffin, C.M. and Fletcher, J.A. (2013) Inflammatory Myofibroblastic Tumor. In: Fletcher, C.D.M., Bridge, J.A., Hogendoorn, P. and Mertens, F., Eds., WHO Classification of Tumours of Soft Tissue and Bone, 4th Edition, International Agency for Research on Cancer, Lyon, 83-84.
|
[15]
|
Parra-Herran, C. and Howitt, B.E. (2019) Uterine Mesenchymal Tumors Update on Classification, Staging, and Molecular Features. Surgical Pathology Clinics, 12, 363-396. https://doi.org/10.1016/j.path.2019.01.004
|
[16]
|
Wojcik, J. (2017) Inflammatory Myofibroblastic Tumor with Marked Pseudodecidual Change. United States and Canadian Academy of Pathology, Palm Springs. http://materials.uscap.org/2017specsurg_h4_55518.asp
|
[17]
|
Gleason, B.C. and Hornick, J.L. (2008) Inflammatory My-ofibroblastic Tumours: Where Are We Now? Journal of Clinical Pathology, 61, 428-437. https://doi.org/10.1136/jcp.2007.049387
|
[18]
|
Etlinger, P., Kuthi, L. and Kovács, T. (2020) Inflammatory Myofi-broblastic Tumors in the Uterus: Childhood-Case Report and Review of the Literature. Frontiers in Pediatrics, 8, Article No. 36.
https://doi.org/10.3389/fped.2020.00036
|
[19]
|
Mossé, Y.P. (2016) Anaplastic Lymphoma Kinase as a Cancer Tar-get in Pediatric Malignancies. Clinical Cancer Research, 22, 546-552. https://doi.org/10.1158/1078-0432.CCR-14-1100
|
[20]
|
Mossé, Y.P., Voss, S.D., Lim, S., Rolland, D., Minard, C.G., Fox, E., et al. (2017) Targeting ALK with Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflamma-tory Myofibroblastic Tumor: A Children’s Oncology Group Study. Journal of Clinical Oncology, 28, 3215-3222. https://doi.org/10.1200/JCO.2017.73.4830
|